Tipping Point Stocks | Market Analysts

28 Jun Intrexon Update

Posted at 09:02h in Portfolio Updates

XON $ 13.20 Biotech under pressure, convertible offering added more...

We actually had two TPS Position reports written up earlier this week with plans to release one of them. One of the stocks literally ran up 20% while we were finishing the report and breaking out of a long base pattern, so we didnt want...

18 Jun XSPL Update

Posted at 12:34h in Portfolio Updates

XSPL $8.50 area Huge move in XSPL earlier this morning as high as $11.70 from $7.56 close last Friday. We have been saying to buy from 6.50-7.75 inclusive, and we also said we were accumulating quite a few shares ourselves under $7 recently. The reason is besides...

11 Jun Portfolio Updates

Posted at 13:57h in Portfolio Updates

Today we are doing some quick notes and charts on all 6 positions, plus notes on buy ranges. Strategy Update: Recent IPO research work coming next! Our next 2-3 TPS Positions are going to be companies that have IPO'd within the last several weeks to 9-12 months....

30 May TPS Chart Updates

Posted at 09:25h in Portfolio Updates

Today we have Chart updates on all 6 positions and some general buy range notes, see each chart for annotations: XSPL Update: In the low end of our suggested 6.50-7.75 buy ranges. We said this stock could air pocket up and down due to thin float,...

25 May Position Updates and News

Posted at 08:34h in Portfolio Updates

Today we are updating developments if any on the 6 open positions, we did charts and brief technical notes on Wednesday this week: CLLS- $31- Cellectis effectively has about 480 million in cash, plus a 74% stake in CLXT. CLXT has 32 million shares outstanding now after...

23 May TPS Position Updates

Posted at 14:50h in Portfolio Updates

We are updating 6 positions for the TPS Portfolio as we work towards our goal of 12 positions. Right now we have 1/2 position on AQMS and 5 Full Positions on CLLS, EXPI, ADAP, XON, and working on XSPL. CLLS is a strong buy at 24-28 and...

22 May TPS Buy Report- XSPL- Xspand Products Lab Inc

Posted at 08:39h in Research Reports

XSPL- $7 area Corporate Website Share Structure: Extremely Favorable for Investors *4.3 Million Common Shares *4.75 Million Fully Diluted Shares (*450,000 of the 4.75 MM shares are for an employee ESOP program and not yet issued) Fully Diluted Market Capitalization 33 Million at $7 No outstanding warrants Management and Insiders owns 3 Million...

18 May TPS Position Updates

Posted at 09:59h in Portfolio Updates

Updating all 5 positions in the TPS Portfolio 1/2 Long AQMS Full Positions on CLLS, EXPI, ADAP, AQMS New TPS Report Due: Monday or Tuesday next week. We are completing a full research report on a recent IPO that is flying under the radar for several reasons which we...

15 May EXPI Quarterly Report Update

Posted at 08:49h in Portfolio Updates

EXPI 14.20 First written up at $6.44 with a $7.25 Max buy , later $8.50 EXPI just reported their 1st quarter 2018 results with revenues exploding year over year up 188% and Agent count nearly tripling. Q1 2018 Highlights $62 million in revenue, 188% increase year-over-year Nearly tripled...